Director/PDMR Shareholding

GSK PLC

02 December 2024

 

GSK plc (the 'Company')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Sally Jackson
b)	Position/status	SVP, Global Communications and CEO Office
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GSK plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	Ordinary shares of 31 ¼ pence each ('Ordinary Shares') ISIN: GB00BN7SWP63
b)	Nature of the transaction	The grant of options over Ordinary Shares pursuant to the Company's Share Save Plan 2022
c)	Price(s) and volume(s)	Price(s) Volume(s) £11.27 822
d)	Aggregated information Aggregated volume Price	N/A (single transaction)
e)	Date of the transaction	2024-11-28
f)	Place of the transaction	London Stock Exchange (XLON)

 

END